Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 101 - 125 of 352
BCL6 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BCL6 IHC Disease Lymphoma (mantle cell lymphoma, MALToma and anaplastic large cell lymphomas)BCL6 is a transcriptional suppressor
BerEP4 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BEREP4 IHC Disease Basal Cell Carcinoma (BCC)BerEP4 is a monoclonal antibody that can be used as a marker of BCC. It works by
Beta HCG Alternative Name Human Chorionic Gonadotropin Beta Methodology Immunohistochemistry (IHC) Test Description Probes/Genes HCG IHC Disease Choriocarcinomas, germ cell tumorsHuman chorionic gonadotropin
Beta-Catenin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes Beta-Catenin IHC Disease Colorectal cancer resulting from familial adenomatous polyposis (FAP)The IHC Beta Catenin test
Bg8 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BG8 IHC Disease Adenocarcinoma, excludig mesotheliomaBG8 Lewisy, also known as Lewisy Blood Antigen or simply BG8, is a blood group
BOB1 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BOB1 IHC Disease Hodgkin lymphomaBOB1 is present in all B-cells expressing Ig. BOB-1 antibody is a B-lymphocyte-specific transcriptional
BRAF by IHC Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BRAF IHC Disease Hairy Cell Leukemia, melanoma, thyroid cancer, lung cancer, NHL, langerhans cell histiocytosis (LCH)Serine/threonine-protein
CA-125 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CA125IHC Disease ovarian malignancies, cervical carcinoma, seminal vesicle carcinoma, anaplastic lymphoma, and endometrial and
CA19.9 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CA199 IHC Disease Pancreatic Cancer, colorectal cancerCA-19-9, also called cancer antigen-19-9 or sialylated Lewis (a) antigen,
Caldesmon Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CALDES IHC Disease Smooth Muscle TumorsCaldesmon is a protein that in humans is encoded by the CALD1 gene. It is a smooth
Calponin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CALPON IHC Disease Tumors of smooth muscle or myoepithelial lineage,(especially urogenital tract), infiltrating breast carcinoma.Basic
Calretinin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CALRET IHC Disease mesothelioma, adrenocortical tumors.Calretinin is a calcium-binding protein originally found in neurons.
CAM5.2 (CK8/18/19) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CAM5 IHC Disease Epithelial cells tumorsAnti-Cytokeratin (CAM 5.2) has a primary reactivity with human keratin proteins
CD10 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD10 IHC Disease Lymphoma (lymphoblastic, Burkitt's and follicular lymphomas.), endometrial stromal sarcoma.CD10 antigen, Also
CD103 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD103 IHC Disease Lymphoma (hairy cell leukemia, enteropathy associated T-cell lymphoma, and some splenic marginal zone lymphomas.)CD103
CD117 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD117 IHC Disease Gastrointestinal Stromal Tumors (GISTs), mast cell diseases, acute myeloid leukemia (AML), small cell lung carcinoma
CD117(C-KIT) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD117 (C-KIT) IHC Disease Gastrointestinal Stromal Tumors (GISTs), mast cell diseases, acute myeloid leukemia (AML), small
CD138 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD138 IHC Disease Plasma Cell Dyscrasia, primary effusion lymphoma.CD138 molecule is a transmembrane heparan sulphate glycoprotein
CD15 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD15 IHC Disease Hodgkin's LymphomaCD15 antigen, also known as X-hapten, is reported to be expressed on 90% of circulating human
CD163 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD163 IHC Disease Hodgkin's lymphoma, Histiocytic Sarcoma, Non-Langerhans-Cell Histiocytosis.The protein encoded by this gene
CD1a Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD1A IHC Disease Cutaneous T-cell lymphomas, Langerhans cell histiocytosis.CD1a is expressed on dendritic cells and cortical thymocytes.
CD2 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD2 IHC Disease T-cell Lymphomas, NK cell malignancies, colorectal cancer, urethelial cancer, breast cancer, prostate cancer, lung
CD20 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD20 IHC Disease Lymphoma (B-cell lymphomas: B-ALL/B-LBL, lymphocyte predominant Hodgkin lymphoma, spindle cell thymomas)B-lymphocyte
CD21 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD21 IHC Disease Follicular, mantle cell lymphomas, and mature leukemiasCD21 antigen is a type I integral membrane glycoprotein
CD23 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD23 IHC Disease Lymphomas, and B-cell chronic lymphomocytic leukaemiasCD23 can be demonstrated in germinal centre follicular dendritic
With core values rooted in service and integrity, our leadership team sets the bar high.
We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.
siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).
We also hold select state licensure where required.